Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Non Operating Investment Income: 2020-2022

Historic Non Operating Investment Income for Avidity Biosciences (RNA) over the last 3 years, with Dec 2022 value amounting to -$2.5 million.

  • Avidity Biosciences' Non Operating Investment Income fell 18.44% to -$1.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $320,000, marking a year-over-year increase of 110.72%. This contributed to the annual value of -$2.5 million for FY2022, which is 1279.67% down from last year.
  • Avidity Biosciences' Non Operating Investment Income amounted to -$2.5 million in FY2022, which was down 1,279.67% from -$182,000 recorded in FY2021.
  • In the past 5 years, Avidity Biosciences' Non Operating Investment Income ranged from a high of -$5,000 in FY2020 and a low of -$2.5 million during FY2022.
  • Over the past 3 years, Avidity Biosciences' median Non Operating Investment Income value was -$182,000 (recorded in 2021), while the average stood at -$899,333.
  • Data for Avidity Biosciences' Non Operating Investment Income shows a maximum YoY plummeted of 3,540.00% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Avidity Biosciences' Non Operating Investment Income stood at -$5,000 in 2020, then crashed by 3,540.00% to -$182,000 in 2021, then slumped by 1,279.67% to -$2.5 million in 2022.